For the survivin rs9904341, a significantly increased tumor risk was found for C/C vs. G/G (OR = 1.40, 95% CI = 1.13–1.74, p = 0.002), dominant (OR = 1.18, 95% CI = 1.01–1.38, p = 0.039) and recessive (OR = 1.34, 95% CI = 1.13–1.58, p = 0.001) genetic models, while there was no significant association of this SNP with tumor risk under allele frequency comparison model and C/C vs. G/G genetic model (Table 2, Figure 3). This evidence concerns the gene BIRC5 and neoplasm.